Shockwave Medical Reports Fourth Quarter and Full Year 2022 Financial Results
16 févr. 2023 16h02 HE
|
Shockwave Medical, Inc.
SANTA CLARA, Calif., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex...
Updated SCAI Guidance Includes Coronary IVL as a Treatment Option in All U.S. Catheterization Labs Regardless of Surgical Backup Status
31 janv. 2023 08h00 HE
|
Shockwave Medical, Inc.
SANTA CLARA, Calif., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified...
Shockwave Medical Announces Agreement to Acquire Neovasc
17 janv. 2023 08h00 HE
|
Shockwave Medical, Inc.
Neovasc’s Innovative Reducer System Will Target the Estimated $5 Billion Refractory Angina Market Shockwave Medical Announces Preliminary Fourth Quarter and Full Year 2022 Revenues and Full Year 2023...
Shockwave Medical Provides Quarterly Earnings Release Dates for 2023
04 janv. 2023 16h05 HE
|
Shockwave Medical, Inc.
SANTA CLARA, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex...
Shockwave Medical to Participate in the Piper Sandler 34th Annual Healthcare Conference
22 nov. 2022 08h30 HE
|
Shockwave Medical, Inc.
SANTA CLARA, Calif., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified...
Shockwave Medical Publishes Inaugural ESG Report
16 nov. 2022 08h30 HE
|
Shockwave Medical, Inc.
SANTA CLARA, Calif., Nov. 16, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified...
Shockwave Medical Reports Third Quarter 2022 Financial Results
07 nov. 2022 16h03 HE
|
Shockwave Medical, Inc.
SANTA CLARA, Calif., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex...
Shockwave Confirms Consistent Outcomes for IVL in the Largest Prospective “Real World” Study of Patients with Heavily Calcified Peripheral Arterial Disease
01 nov. 2022 14h45 HE
|
Shockwave Medical, Inc.
LAS VEGAS, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular...
Shockwave Medical Announces Details for Conference Call Discussing Third Quarter 2022 Results
20 oct. 2022 08h30 HE
|
Shockwave Medical, Inc.
SANTA CLARA, Calif., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified...
Shockwave Medical Initiates All-Female Coronary IVL Study
19 sept. 2022 09h00 HE
|
Shockwave Medical, Inc.
EMPOWER CAD is the First Prospective, Female-Only Study of Coronary Interventions Study Seeks to Confirm Benefits of Shockwave’s Coronary IVL in Females Who Historically Have Suffered Less Favorable...